Trials / Completed
CompletedNCT00757731
FMS European Long-Term Study
A European Phase III, Multicentre, Double-blind, Randomised, Monotherapy, 12-month Study of Milnacipran for the Treatment of the Fibromyalgia Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 490 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- All
- Age
- 18 Years – 71 Years
- Healthy volunteers
- Not accepted
Summary
Investigation of the long-term (12 months) efficacy and safety of milnacipran used in the treatment of fibromyalgia syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | milnacipran | hard capsule |
| DRUG | Placebo | hard capsule |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2008-09-23
- Last updated
- 2013-07-11
Locations
10 sites across 10 countries: Czechia, Finland, France, Germany, Italy, Norway, Portugal, Romania, Spain, Sweden
Source: ClinicalTrials.gov record NCT00757731. Inclusion in this directory is not an endorsement.